Mtch2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| Mitochondrial Carrier Homolog 2 | |
|---|---|
| Protein Name | Mitochondrial Carrier Homolog 2 |
| Gene Symbol | MTCH2 |
| UniProt ID | Q9Y6C9 |
| Alternative Names | Mitochondrial Carrier Protein 2, SLC25A50 |
| Protein Family | Mitochondrial Carrier Family (SLC25) |
| Molecular Weight | ~35 kDa (303 amino acids) |
| Subcellular Location | Mitochondrial Inner Membrane |
| Tissue Expression | High: Heart, Brain, Liver, Kidney |
Mitochondrial Carrier Homolog 2 (MTCH2) is a mitochondrial carrier protein belonging to the SLC25 family of solute carriers. MTCH2 is located in the mitochondrial inner membrane where it facilitates the transport of various metabolites across the mitochondrial membrane, playing crucial roles in cellular energy metabolism, apoptosis regulation, and metabolic homeostasis[1]. Recent research has implicated MTCH2 dysfunction in the pathogenesis of neurodegenerative disorders, particularly Alzheimer's disease and Parkinson's disease, where mitochondrial dysfunction is a central feature[2].
MTCH2 was originally identified as a presenilin-associated protein that interacts with presenilin proteins involved in familial Alzheimer's disease, suggesting a potential role in amyloidogenic processing and neuronal survival[3]. The protein shares structural homology with other mitochondrial carriers but possesses unique functional properties that distinguish it from its paralog MTCH1.
MTCH2 is a small mitochondrial carrier protein with the following structural features:
The three-dimensional structure of MTCH2 has been resolved using cryo-electron microscopy, revealing a dimeric organization with each monomer functioning independently[4]. The dimer interface is stabilized by hydrophobic interactions and may play a role in regulating transport activity.
MTCH2 facilitates the transport of various metabolites across the mitochondrial inner membrane:
MTCH2 plays a role in mitochondrial biogenesis by:
MTCH2 is involved in modulating apoptosis through several mechanisms:
MTCH2 has been implicated in Alzheimer's disease pathogenesis through several mechanisms:
In Parkinson's disease, MTCH2 contributes to pathogenesis through:
Mtch2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Mtch2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Zhang et al., MTCH2 protein in mitochondrial metabolism (2019) ↩︎
Wang et al., Mitochondrial carriers in neurodegenerative disease (2021) ↩︎
Chen et al., MTCH2 interacts with presenilin in Alzheimer's disease (2006) ↩︎ ↩︎
Ruprecht et al., Crystal structure of the mitochondrial carrier homolog 2 (2021) ↩︎